Global Ivosidenib Drugs Market

Ivosidenib Drugs Comprehensive Study by Type (60 Tablets, 30 Tablets), Application (Hospital, Pharmacy) Players and Region - Global Market Outlook to 2026

Ivosidenib Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Ivosidenib Drugs Market Scope?
This is the drug that is sold under the brand name of Tibsovo. This is the medication that is used to treat myeloid leukemia. The drug is still in development by Agios Pharmaceuticals and is in the third phase of the trial. Ivosidenib drug is used for the newly diagnosed. This tablet can be taken with or without food intake. The medicine should not be stopped unless prescribed by the doctor. There should not be any extra dose taken if missed. The drug also has some side effects which is restricting the growth of the market.

The Ivosidenib Drugs market study is being classified by Type (60 Tablets and 30 Tablets), by Application (Hospital and Pharmacy) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Agios Pharmaceuticals (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Ivosidenib Drugs market by Type, Application and Region.

On the basis of geography, the market of Ivosidenib Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).


On May 2, 2019, the Food and Drug Administration (FDA) had thereby approved the drug named Ivosidenib (TIBSOVO, Agios Pharmaceuticals, Inc.) for the purpose of recently diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation tested in the patients, who are of 75 years or are older and have comorbidities, that henceforth prevent the use of intensive induction chemotherapy.

Influencing Market Trend
  • A Rise in The Smoking Habits of Younger Generation

Market Drivers
  • Increase in The Cases of Myeloid Leukaemia
  • Rising Cases in Liver, Spleen, Brain and Spinal Cord
  • A Rise in the Cases of Genetic Disorders

Opportunities
  • Growing Improvements and Developments Across the Healthcare Industry

Restraints
  • High Cost of the Drug

Challenges
  • Side Effects of the Drug


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Ivosidenib Drugs, Suppliers and Distributors of Ivosidenib Drugs, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • 60 Tablets
  • 30 Tablets
By Application
  • Hospital
  • Pharmacy
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in The Cases of Myeloid Leukaemia
      • 3.2.2. Rising Cases in Liver, Spleen, Brain and Spinal Cord
      • 3.2.3. A Rise in the Cases of Genetic Disorders
    • 3.3. Market Challenges
      • 3.3.1. Side Effects of the Drug
    • 3.4. Market Trends
      • 3.4.1. A Rise in The Smoking Habits of Younger Generation
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ivosidenib Drugs, by Type, Application and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Ivosidenib Drugs (Value)
      • 5.2.1. Global Ivosidenib Drugs by: Type (Value)
        • 5.2.1.1. 60 Tablets
        • 5.2.1.2. 30 Tablets
      • 5.2.2. Global Ivosidenib Drugs by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Pharmacy
      • 5.2.3. Global Ivosidenib Drugs Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Ivosidenib Drugs (Volume)
      • 5.3.1. Global Ivosidenib Drugs by: Type (Volume)
        • 5.3.1.1. 60 Tablets
        • 5.3.1.2. 30 Tablets
      • 5.3.2. Global Ivosidenib Drugs by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Pharmacy
      • 5.3.3. Global Ivosidenib Drugs Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Ivosidenib Drugs (Price)
      • 5.4.1. Global Ivosidenib Drugs by: Type (Price)
  • 6. Ivosidenib Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agios Pharmaceuticals (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
  • 7. Global Ivosidenib Drugs Sale, by Type, Application and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Ivosidenib Drugs (Value)
      • 7.2.1. Global Ivosidenib Drugs by: Type (Value)
        • 7.2.1.1. 60 Tablets
        • 7.2.1.2. 30 Tablets
      • 7.2.2. Global Ivosidenib Drugs by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Pharmacy
      • 7.2.3. Global Ivosidenib Drugs Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Ivosidenib Drugs (Volume)
      • 7.3.1. Global Ivosidenib Drugs by: Type (Volume)
        • 7.3.1.1. 60 Tablets
        • 7.3.1.2. 30 Tablets
      • 7.3.2. Global Ivosidenib Drugs by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Pharmacy
      • 7.3.3. Global Ivosidenib Drugs Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Ivosidenib Drugs (Price)
      • 7.4.1. Global Ivosidenib Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ivosidenib Drugs: by Type(USD Million)
  • Table 2. Ivosidenib Drugs 60 Tablets , by Region USD Million (2015-2020)
  • Table 3. Ivosidenib Drugs 30 Tablets , by Region USD Million (2015-2020)
  • Table 4. Ivosidenib Drugs: by Application(USD Million)
  • Table 5. Ivosidenib Drugs Hospital , by Region USD Million (2015-2020)
  • Table 6. Ivosidenib Drugs Pharmacy , by Region USD Million (2015-2020)
  • Table 7. South America Ivosidenib Drugs, by Country USD Million (2015-2020)
  • Table 8. South America Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 9. South America Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 10. Brazil Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 11. Brazil Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 12. Argentina Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 13. Argentina Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 14. Rest of South America Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 15. Rest of South America Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 16. Asia Pacific Ivosidenib Drugs, by Country USD Million (2015-2020)
  • Table 17. Asia Pacific Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 18. Asia Pacific Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 19. China Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 20. China Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 21. Japan Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 22. Japan Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 23. India Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 24. India Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 25. South Korea Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 26. South Korea Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 27. Taiwan Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 28. Taiwan Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 29. Australia Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 30. Australia Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 31. Rest of Asia-Pacific Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 32. Rest of Asia-Pacific Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 33. Europe Ivosidenib Drugs, by Country USD Million (2015-2020)
  • Table 34. Europe Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 35. Europe Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 36. Germany Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 37. Germany Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 38. France Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 39. France Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 40. Italy Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 41. Italy Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 42. United Kingdom Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 43. United Kingdom Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 44. Netherlands Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 45. Netherlands Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 46. Rest of Europe Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 47. Rest of Europe Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 48. MEA Ivosidenib Drugs, by Country USD Million (2015-2020)
  • Table 49. MEA Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 50. MEA Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 51. Middle East Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 52. Middle East Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 53. Africa Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 54. Africa Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 55. North America Ivosidenib Drugs, by Country USD Million (2015-2020)
  • Table 56. North America Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 57. North America Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 58. United States Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 59. United States Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 60. Canada Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 61. Canada Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 62. Mexico Ivosidenib Drugs, by Type USD Million (2015-2020)
  • Table 63. Mexico Ivosidenib Drugs, by Application USD Million (2015-2020)
  • Table 64. Ivosidenib Drugs Sales: by Type(K Tons)
  • Table 65. Ivosidenib Drugs Sales 60 Tablets , by Region K Tons (2015-2020)
  • Table 66. Ivosidenib Drugs Sales 30 Tablets , by Region K Tons (2015-2020)
  • Table 67. Ivosidenib Drugs Sales: by Application(K Tons)
  • Table 68. Ivosidenib Drugs Sales Hospital , by Region K Tons (2015-2020)
  • Table 69. Ivosidenib Drugs Sales Pharmacy , by Region K Tons (2015-2020)
  • Table 70. South America Ivosidenib Drugs Sales, by Country K Tons (2015-2020)
  • Table 71. South America Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 72. South America Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 73. Brazil Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 74. Brazil Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 75. Argentina Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 76. Argentina Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 77. Rest of South America Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 78. Rest of South America Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 79. Asia Pacific Ivosidenib Drugs Sales, by Country K Tons (2015-2020)
  • Table 80. Asia Pacific Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 81. Asia Pacific Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 82. China Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 83. China Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 84. Japan Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 85. Japan Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 86. India Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 87. India Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 88. South Korea Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 89. South Korea Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 90. Taiwan Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 91. Taiwan Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 92. Australia Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 93. Australia Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 94. Rest of Asia-Pacific Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 95. Rest of Asia-Pacific Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 96. Europe Ivosidenib Drugs Sales, by Country K Tons (2015-2020)
  • Table 97. Europe Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 98. Europe Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 99. Germany Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 100. Germany Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 101. France Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 102. France Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 103. Italy Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 104. Italy Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 105. United Kingdom Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 106. United Kingdom Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 107. Netherlands Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 108. Netherlands Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 109. Rest of Europe Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 110. Rest of Europe Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 111. MEA Ivosidenib Drugs Sales, by Country K Tons (2015-2020)
  • Table 112. MEA Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 113. MEA Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 114. Middle East Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 115. Middle East Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 116. Africa Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 117. Africa Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 118. North America Ivosidenib Drugs Sales, by Country K Tons (2015-2020)
  • Table 119. North America Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 120. North America Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 121. United States Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 122. United States Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 123. Canada Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 124. Canada Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 125. Mexico Ivosidenib Drugs Sales, by Type K Tons (2015-2020)
  • Table 126. Mexico Ivosidenib Drugs Sales, by Application K Tons (2015-2020)
  • Table 127. Ivosidenib Drugs: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Ivosidenib Drugs: by Type(USD Million)
  • Table 130. Ivosidenib Drugs 60 Tablets , by Region USD Million (2021-2026)
  • Table 131. Ivosidenib Drugs 30 Tablets , by Region USD Million (2021-2026)
  • Table 132. Ivosidenib Drugs: by Application(USD Million)
  • Table 133. Ivosidenib Drugs Hospital , by Region USD Million (2021-2026)
  • Table 134. Ivosidenib Drugs Pharmacy , by Region USD Million (2021-2026)
  • Table 135. South America Ivosidenib Drugs, by Country USD Million (2021-2026)
  • Table 136. South America Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 137. South America Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 138. Brazil Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 139. Brazil Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 140. Argentina Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 141. Argentina Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 142. Rest of South America Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 143. Rest of South America Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 144. Asia Pacific Ivosidenib Drugs, by Country USD Million (2021-2026)
  • Table 145. Asia Pacific Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 146. Asia Pacific Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 147. China Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 148. China Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 149. Japan Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 150. Japan Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 151. India Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 152. India Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 153. South Korea Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 154. South Korea Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 155. Taiwan Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 156. Taiwan Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 157. Australia Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 158. Australia Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 161. Europe Ivosidenib Drugs, by Country USD Million (2021-2026)
  • Table 162. Europe Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 163. Europe Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 164. Germany Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 165. Germany Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 166. France Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 167. France Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 168. Italy Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 169. Italy Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 170. United Kingdom Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 171. United Kingdom Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 172. Netherlands Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 173. Netherlands Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 174. Rest of Europe Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 175. Rest of Europe Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 176. MEA Ivosidenib Drugs, by Country USD Million (2021-2026)
  • Table 177. MEA Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 178. MEA Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 179. Middle East Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 180. Middle East Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 181. Africa Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 182. Africa Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 183. North America Ivosidenib Drugs, by Country USD Million (2021-2026)
  • Table 184. North America Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 185. North America Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 186. United States Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 187. United States Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 188. Canada Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 189. Canada Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 190. Mexico Ivosidenib Drugs, by Type USD Million (2021-2026)
  • Table 191. Mexico Ivosidenib Drugs, by Application USD Million (2021-2026)
  • Table 192. Ivosidenib Drugs Sales: by Type(K Tons)
  • Table 193. Ivosidenib Drugs Sales 60 Tablets , by Region K Tons (2021-2026)
  • Table 194. Ivosidenib Drugs Sales 30 Tablets , by Region K Tons (2021-2026)
  • Table 195. Ivosidenib Drugs Sales: by Application(K Tons)
  • Table 196. Ivosidenib Drugs Sales Hospital , by Region K Tons (2021-2026)
  • Table 197. Ivosidenib Drugs Sales Pharmacy , by Region K Tons (2021-2026)
  • Table 198. South America Ivosidenib Drugs Sales, by Country K Tons (2021-2026)
  • Table 199. South America Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 200. South America Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 201. Brazil Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 202. Brazil Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 203. Argentina Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 204. Argentina Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 205. Rest of South America Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 206. Rest of South America Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 207. Asia Pacific Ivosidenib Drugs Sales, by Country K Tons (2021-2026)
  • Table 208. Asia Pacific Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 209. Asia Pacific Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 210. China Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 211. China Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 212. Japan Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 213. Japan Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 214. India Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 215. India Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 216. South Korea Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 217. South Korea Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 218. Taiwan Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 219. Taiwan Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 220. Australia Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 221. Australia Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 222. Rest of Asia-Pacific Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 223. Rest of Asia-Pacific Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 224. Europe Ivosidenib Drugs Sales, by Country K Tons (2021-2026)
  • Table 225. Europe Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 226. Europe Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 227. Germany Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 228. Germany Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 229. France Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 230. France Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 231. Italy Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 232. Italy Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 233. United Kingdom Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 234. United Kingdom Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 235. Netherlands Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 236. Netherlands Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 237. Rest of Europe Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 238. Rest of Europe Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 239. MEA Ivosidenib Drugs Sales, by Country K Tons (2021-2026)
  • Table 240. MEA Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 241. MEA Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 242. Middle East Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 243. Middle East Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 244. Africa Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 245. Africa Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 246. North America Ivosidenib Drugs Sales, by Country K Tons (2021-2026)
  • Table 247. North America Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 248. North America Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 249. United States Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 250. United States Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 251. Canada Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 252. Canada Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 253. Mexico Ivosidenib Drugs Sales, by Type K Tons (2021-2026)
  • Table 254. Mexico Ivosidenib Drugs Sales, by Application K Tons (2021-2026)
  • Table 255. Ivosidenib Drugs: by Type(USD/Units)
  • Table 256. Research Programs/Design for This Report
  • Table 257. Key Data Information from Secondary Sources
  • Table 258. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ivosidenib Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Ivosidenib Drugs: by Application USD Million (2015-2020)
  • Figure 6. South America Ivosidenib Drugs Share (%), by Country
  • Figure 7. Asia Pacific Ivosidenib Drugs Share (%), by Country
  • Figure 8. Europe Ivosidenib Drugs Share (%), by Country
  • Figure 9. MEA Ivosidenib Drugs Share (%), by Country
  • Figure 10. North America Ivosidenib Drugs Share (%), by Country
  • Figure 11. Global Ivosidenib Drugs: by Type K Tons (2015-2020)
  • Figure 12. Global Ivosidenib Drugs: by Application K Tons (2015-2020)
  • Figure 13. South America Ivosidenib Drugs Share (%), by Country
  • Figure 14. Asia Pacific Ivosidenib Drugs Share (%), by Country
  • Figure 15. Europe Ivosidenib Drugs Share (%), by Country
  • Figure 16. MEA Ivosidenib Drugs Share (%), by Country
  • Figure 17. North America Ivosidenib Drugs Share (%), by Country
  • Figure 18. Global Ivosidenib Drugs: by Type USD/Units (2015-2020)
  • Figure 19. Global Ivosidenib Drugs share by Players 2020 (%)
  • Figure 20. BCG Matrix for key Companies
  • Figure 21. Agios Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 22. Agios Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 23. Global Ivosidenib Drugs: by Type USD Million (2021-2026)
  • Figure 24. Global Ivosidenib Drugs: by Application USD Million (2021-2026)
  • Figure 25. South America Ivosidenib Drugs Share (%), by Country
  • Figure 26. Asia Pacific Ivosidenib Drugs Share (%), by Country
  • Figure 27. Europe Ivosidenib Drugs Share (%), by Country
  • Figure 28. MEA Ivosidenib Drugs Share (%), by Country
  • Figure 29. North America Ivosidenib Drugs Share (%), by Country
  • Figure 30. Global Ivosidenib Drugs: by Type K Tons (2021-2026)
  • Figure 31. Global Ivosidenib Drugs: by Application K Tons (2021-2026)
  • Figure 32. South America Ivosidenib Drugs Share (%), by Country
  • Figure 33. Asia Pacific Ivosidenib Drugs Share (%), by Country
  • Figure 34. Europe Ivosidenib Drugs Share (%), by Country
  • Figure 35. MEA Ivosidenib Drugs Share (%), by Country
  • Figure 36. North America Ivosidenib Drugs Share (%), by Country
  • Figure 37. Global Ivosidenib Drugs: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Agios Pharmaceuticals (United States)
Select User Access Type

Key Highlights of Report


Apr 2021 248 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Ivosidenib Drugs Market Quantitative research analysis
Global Ivosidenib Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Ivosidenib Drugs market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Ivosidenib Drugs market are Agios Pharmaceuticals (United States), to name a few.
In this highly competitive & fast evolving Ivosidenib Drugs industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Ivosidenib Drugs Market Report?

Have a Query? Click Here

Other Related Reports

Tuberculosis Vaccines Comprehensive Study by Type (Immunotherapeutic Vaccines, Booster Vaccines, Others), Application (Hospitals, Clinics, Others), Testing Type (Tuberculin Skin Test (TST), TB Blood ...
$ 3500
Sulbactam Pivoxil Comprehensive Study by Application (Pharmaceutical, Research, Biosciences, Others), Form (Tablets, Powder, Suspension), Distribution Channel (Hospitals Pharmacies, Medical Stores, O...
$ 3450
Benzocaine Drugs Comprehensive Study by Type (Gel, Aerosol, Paste, Cream), Application (Dental Clinics, Hospital, Pharmacy/Drugstore), Indication (Skin Irritation, Wounds, Ulcers, Hemorrhoids, Others...
$ 3450
Ofloxacin Comprehensive Study by Type (Oral, Intravenous Therapy (IV), Topical (Eye Drops & Ear Drops)), Application (Bronchitis, Pneumonia and Infections of the Skin, Reproductive Organs, Bladder, U...
$ 3750
Dental Anesthesia Comprehensive Study by Type (Local Anesthesia, General Anesthesia), Application (Hospital, Clinic, Other), Drugs (Lidocaine, Mepivacaine, Prilocaine, Bupivacaine), Mode Of Administr...
$ 3350
Cannabidiol (CBD) Comprehensive Study by Type (Recreational, Medicinal, Synthetic.), Application (CBD For Food & beverage, CBD Cosmetics & personal Care, CBD Pharmaceutical, Other), Variants (Genus, ...
$ 3800